Exploration on the Comprehensive Advantages of Integrative Chinese and Western Medicine in the Treatment of Parkinson's Disease
DOI:
https://doi.org/10.53469/jcmp.2024.06(11).26Keywords:
Parkinson's disease, Treatment with traditional Chinese medicine, Integration of traditional Chinese medicine and western medicine, Comprehensive advantageAbstract
Parkinson's disease is a chronic neurodegenerative disease, which is prone to occur in the middle-aged and elderly. With the progression of the disease, multiple systems can be affected, and eventually the patient becomes disabled. This not only seriously affects the patient's work and life, but also brings a heavy burden to society and family. Although Parkinson's disease is characterized by incurability and high disability, it has a long course and slow progression with strong clinical intervention. Based on this, the reasonable, effective and long-term diagnosis and treatment of Parkinson's disease are put forward higher requirements. We cannot deny that western medicine plays a pivotal role in the treatment of Parkinson's disease. However, with the aggravation of motor symptoms and non-motor symptoms as well as the emergence of adverse drug reactions and motor complications, the limitations of western medicine in the diagnosis and treatment of Parkinson's disease have become increasingly prominent. A large number of clinical studies have shown that traditional Chinese medicine has significant advantages in the treatment of Parkinson's disease, especially in the early stage of Parkinson's disease and the improvement of non-motor symptoms of Parkinson's disease. Therefore, the treatment of Parkinson's disease with traditional Chinese medicine should not only become a beneficial attempt in its clinical research and diagnosis, but also become a routine process in the diagnosis and treatment of Parkinson's disease. Integrative Chinese and Western medicine can complement each other, improve the curative effect, reduce the side effects of western medicine, and effectively control the motor and non-motor symptoms of Parkinson's disease.
References
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019 [J]. Lancet Neurol, 2021, 20(10):795-820.
Dorsey E R, Constantinescu R, Thompson J P, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030 [J]. Neurology, 2007, 68(5):384-386.
Li G, Ma J, Cui S, et al. Parkinson's disease in China: a forty-year growing track of bedside work [J]. Transl Neurodegener, 2019, 8:22.
Schapira A H. Treatment options in the modern management of Parkinson disease [J]. Arch Neurol, 2007, 64(8):1083-1088.
Jia Jianping, Wujiang. Neurology [M]. 3rd ed. Beijing: People's Health Publishing House, 2020:291-292.
Jellinger K A. Neuropathobiology of non-motor symptoms in Parkinson disease [J]. J Neural Transm (Vienna), 2015, 122(10):1429-1440.
Radder D, de Vries N M, Riksen N P, et al. Multidisciplinary care for people with Parkinson's disease: the new kids on the block! [J]. Expert Rev Neurother, 2019, 19(2):145-157.
Sonntag K C, Song B, Lee N, et al. Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects [J]. Prog Neurobiol, 2018, 168: 1-20.
Neurologist of Chinese Medical Association, Parkinson's Disease and Movement Disorder Group and Branch Parkinson's Disease and Movement Disorder Group of Neurology Association of Chinese Medical Association, China Guidelines for the Treatment of Parkinson's Disease (Fourth Edition [J]. Chinese Journal of Neurology, 2020, 53 (12):973-986.
Tolosa E, Garrido A, Scholz S W, et al. Challenges in the diagnosis of Parkinson's disease [J]. Lancet Neurol, 2021, 20(5):385-397.
Bloem B R, Okun M S, Klein C. Parkinson's disease [J]. Lancet, 2021, 397(10291):2284-2303.
Leite S A, Gonçalves D O R, Diógenes G P, et al. Premotor, nonmotor and motor symptoms of Parkinson's Disease: A new clinical state of the art [J]. Ageing Res Rev, 2023, 84:101834.
Schapira A, Chaudhuri K R, Jenner P. Non-motor features of Parkinson disease [J]. Nat Rev Neurosci, 2017, 18(8):509.
Armstrong M J, Okun M S. Diagnosis and Treatment of Parkinson Disease: A Review [J]. JAMA, 2020, 323(6):548-560.
Ahn E H, Kang S S, Liu X, et al. Initiation of Parkinson's disease from gut to brain by δ-secretase [J]. Cell Res, 2020, 30(1):70-87.
Weintraub D, Aarsland D, Chaudhuri K R, et al. The neuropsychiatry of Parkinson's disease: advances and challenges [J]. Lancet Neurol, 2022, 21(1):89-102.
Williams-Gray C H, Mason S L, Evans J R, et al. The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort [J]. J Neurol Neurosurg Psychiatry, 2013, 84(11):1258-1264.
Hely M A, Reid W G, Adena M A, et al. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years [J]. Mov Disord, 2008, 23(6):837-844.
Bressman S, Saunders-Pullman R. When to Start Levodopa Therapy for Parkinson's Disease [J]. N Engl J Med, 2019, 380(4):389-390.
Luo Xiaodong, Li Zhe, Zhu Meiling, et al. Expert consensus on TCM clinical diagnosis and treatment of Parkinson's disease (warfarin) [J]. journal of traditional chinese medicine, 2021, 62(23):2109-2116.
Shi Yan and Wu Mianhua. Internal medicine of traditional Chinese medicine [M]. 5. Beijing: Beijing Medical Publishing House, 2021:406-411.
Li Z, Jiang Y, Lu X W, et al. Progress of TCM and western medicine in staging treatment of Parkinson's disease [J]. Zhongnan Pharmacy, 2023, 21(02):470-476.
Morris H R, Spillantini M G, Sue C M, et al. The pathogenesis of Parkinson's disease [J]. Lancet, 2024, 403(10423):293-304.
Wang Lijuan, Chen Haibo, Zhang Yuhu. Evidence-based medicine guidelines for the treatment of motor symptoms of advanced Parkinson's disease in China [J]. China Journal of Neuroimmunology and Neurology, 2021, 28(05):347-360.
Gao Tian. Bazhen Decoction combined with dopa silk hydrazine tablets in the treatment of Parkinson's disease clinical observation of qi and blood deficiency type [D]. Hubei University of Traditional Chinese Medicine, 2021.
Zheng Dachang, Zheng Ying. Effect of Xifeng Dingchan Decoction on UA and SOD levels in patients with dyskinesia of Parkinson's disease due to yin deficiency of liver and kidney [J]. Henan Traditional Chinese Medicine, 2020, 40(03):419-422.
LAN Siyang, Wang Chunchen, Liu Huilin, et al. 17 cases of primary Parkinson's disease were treated with empirical formula of Wang Leting combined with fire needle acupuncture [J]. China Acupuncture, 2019, 39(05):487-488.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Peijuan Fan, Weiyi Hou, Song Du, Xia Wang, Yanni Liu
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
